The increased risk of active tuberculosis disease in patients with dermatomyositis - A nationwide retrospective cohort study

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wu, Ping Hsun ^a,b   Lin, Yi Ting ^c   Yang, Yi Hsin ^d   Lin, Yu Chih ^a   Lin, Yi Ching ^a,e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; COHORT ANALYSIS; COMPLICATION; DERMATOMYOSITIS; FACTUAL DATABASE; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; TAIWAN; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AZATHIOPRINE; COHORT STUDIES; DATABASES, FACTUAL; DERMATOMYOSITIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TAIWAN; TUBERCULOSIS; YOUNG ADULT;

EID: 84947976180     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16303     Document Type: Article

References (42)

1. Callen, J. P. Dermatomyositis. Lancet 355, 53-57, doi: 10. 1016/S0140-6736(99)05157-0 (2000).
2. Schiopu, E., Phillips, K., MacDonald, P. M., Crofford, L. J. & Somers, E. C. Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14, R22, doi: 10. 1186/ar3704 (2012).
3. Taborda, A. L., Azevedo, P. & Isenberg, D. A. Retrospective analysis of the outcome of patients with idiopathic inflammatory myopathy: a long-term follow-up study. Clin Exp Rheumatol 32, 188-193 (2014).
4. Marie, I. et al. Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28, 2230-2237 (2001).
5. Danko, K., Ponyi, A., Constantin, T., Borgulya, G. & Szegedi, G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83, 35-42, doi: 10. 1097/01. md. 0000109755. 65914. 5e (2004).
6. Zumla, A., Raviglione, M., Hafner, R. & von Reyn, C. F. Tuberculosis. N Engl J Med 368, 745-755, doi: 10. 1056/NEJMra1200894 (2013).
7. Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J. & Dye, C. Tuberculosis. Lancet 362, 887-899, doi: 10. 1016/S0140- 6736(03)14333-4 (2003).
8. Hsueh, P. R. et al. Mycobacterium tuberculosis in Taiwan. J Infect 52, 77-85, doi: 10. 1016/j. jinf. 2005. 08. 008 (2006).
9. Gonzalez Leon, R. et al. [Tuberculosis in a cohort of patients with systemic lupus erythematosus]. Reumatol Clin 6, 256-261, doi: 10. 1016/j. reuma. 2009. 11. 002 (2010).
10. Hou, C. L., Tsai, Y. C., Chen, L. C. & Huang, J. L. Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared. Clin Rheumatol 27, 557-563, doi: 10. 1007/s10067-007-0741-8 (2008).
11. Mok, M. Y., Lo, Y., Chan, T. M., Wong, W. S. & Lau, C. S. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. J Rheumatol 32, 609-615 (2005).
12. Baronnet, L. et al. Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 78, 279-284, doi: 10. 1016/j. jbspin. 2010. 12. 004 (2011).
13. Ke, W. M., Chen, L. S., Parng, I. M., Chen, W. W. & On, A. W. Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan. Int J Tuberc Lung Dis 17, 1590-1595, doi: 10. 5588/ijtld. 13. 0368 (2013).
14. Ou, S. M. et al. Systemic sclerosis and the risk of tuberculosis. J Rheumatol 41, 1662-1669, doi: 10. 3899/jrheum. 131125 (2014).
15. Chang, Y. S. et al. Tuberculosis infection in primary Sjogrens syndrome: a nationwide population-based study. Clin Rheumatol 33, 377-383, doi: 10. 1007/s10067-013-2408-y (2014).
16. Chen, I. J. et al. Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology (Oxford) 49, 2429-2437, doi: 10. 1093/rheumatology/keq279 (2010).
17. Marie, I. et al. Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum 41, 48-60, doi: 10. 1016/j. semarthrit. 2010. 08. 003 (2011).
18. Wang, J. Y. et al. Optimal duration of anti-TB treatment in patients with diabetes: nine or six months? Chest 147, 520-528, doi: 10. 1378/chest. 14-0918 (2015).
19. Tansley, S. L., McHugh, N. J. & Wedderburn, L. R. Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and pathogenic mechanisms? Arthritis Res Ther 15, 211, doi: 10. 1186/ ar4198 (2013).
20. Wacholder, S., Silverman, D. T., McLaughlin, J. K. & Mandel, J. S. Selection of controls in case-control studies. III. Design options. Am J Epidemiol 135, 1042-1050 (1992).
21. Chu, H. et al. Risk of tuberculosis among healthcare workers in an intermediate-burden country: a nationwide population study. J Infect 69, 525-532, doi: 10. 1016/j. jinf. 2014. 06. 019 (2014).
22. Lee, C. H. et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One 7, e37978, doi: 10. 1371/journal. pone. 0037978 (2012).
23. Airio, A., Kauppi, M., Kautiainen, H., Hakala, M. & Kinnula, V. High association of mycobacterial infections with polymyositis in a non-endemic country for tuberculosis. Ann Rheum Dis 66, 1404-1405, doi: 10. 1136/ard. 2007. 070177 (2007).
24. Aberra, F. N., Stettler, N., Brensinger, C., Lichtenstein, G. R. & Lewis, J. D. Risk for active tuberculosis in inflammatory bowel disease patients. Clin Gastroenterol Hepatol 5, 1070-1075, doi: 10. 1016/j. cgh. 2007. 04. 007 (2007).
25. Baker, M. A., Lin, H. H., Chang, H. Y. & Murray, M. B. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis 54, 818-825, doi: 10. 1093/cid/cir939 (2012).
26. Jeon, C. Y. & Murray, M. B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 5, e152, doi: 10. 1371/journal. pmed. 0050152 (2008).
27. Wacholder, S., McLaughlin, J. K., Silverman, D. T. & Mandel, J. S. Selection of controls in case-control studies. I. Principles. Am J Epidemiol 135, 1019-1028 (1992).
28. Lawn, S. D. & Zumla, A. I. Tuberculosis. Lancet 378, 57-72, doi: 10. 1016/S0140-6736(10)62173-3 (2011).
29. Chen, Y. J. et al. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 12, R70, doi: 10. 1186/ar2987 (2010).
30. Miettinen, O. S. Individual matching with multiple controls in the case of all-or-none responses. Biometrics 25, 339-355 (1969).
31. Bernatsky, S. et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 68, 1192-1196, doi: 10. 1136/ard. 2008. 093161 (2009).
32. Ohta, A., Nagai, M., Nishina, M., Tomimitsu, H. & Kohsaka, H. Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan. Mod Rheumatol 23, 759-764, doi: 10. 1007/ s10165-012-0733-7 (2013).
33. Liu, C. J. et al. Risk and impact of tuberculosis in patients with chronic myeloid leukemia: a nationwide population-based study in Taiwan. Int J Cancer 136, 1881-1887, doi: 10. 1002/ijc. 29201 (2015).
34. Marinkovic, G., Hamers, A. A., de Vries, C. J. & de Waard, V. 6-Mercaptopurine reduces macrophage activation and gut epithelium proliferation through inhibition of GTPase Rac1. Inflamm Bowel Dis 20, 1487-1495, doi: 10. 1097/ MIB. 0000000000000122 (2014).
35. Chang, C. H., Lee, C. H., Ho, C. C., Wang, J. Y. & Yu, C. J. Gender-based impact of epidermal growth factor receptor mutation in patients with nonsmall cell lung cancer and previous tuberculosis. Medicine (Baltimore) 94, e444, doi: 10. 1097/ MD. 0000000000000444 (2015).
36. Lin, S. Y. et al. Incidence rates of tuberculosis in chronic hepatitis C infected patients with or without interferon based therapy: a population-based cohort study in Taiwan. BMC Infect Dis 14, 705, doi: 10. 1186/s12879-014-0705-y (2014).
37. Fan, W. C. et al. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study. Int J Tuberc Lung Dis 19, 58-64, doi: 10. 5588/ijtld. 14. 0301 (2015).
38. Lin, H. H., Ezzati, M., Chang, H. Y. & Murray, M. Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med 180, 475-480, doi: 10. 1164/rccm. 200904-0549OC (2009).
39. Patra, J., Jha, P., Rehm, J. & Suraweera, W. Tobacco smoking, alcohol drinking, diabetes, low body mass index and the risk of self-reported symptoms of active tuberculosis: individual participant data (IPD) meta-analyses of 72, 684 individuals in 14 high tuberculosis burden countries. PLoS One 9, e96433, doi: 10. 1371/journal. pone. 0096433 (2014).
40. Hernandez-Garduno, E. Association between tobacco smoking and active tuberculosis in Taiwan: is there really an association? Am J Respir Crit Care Med 181, 290-291; author reply 291, doi: 10. 1164/ajrccm. 181. 3. 290 (2010).
41. Lo, H. Y., Chou, P., Yang, S. L., Lee, C. Y. & Kuo, H. S. Trends in tuberculosis in Taiwan, 2002-2008. J Formos Med Assoc 110, 501-510, doi: 10. 1016/S0929-6646(11)60076-4 (2011).
42. Liao, C. M. et al. Assessing trends and predictors of tuberculosis in Taiwan. BMC Public Health 12, 29, doi: 10. 1186/1471-2458- 12-29 (2012).